BiomX to Present at Upcoming January Investor Conferences

Rhea-AI Summary

BiomX (NYSE American: PHGE), a clinical-stage biotechnology company, has announced that CEO Jonathan Solomon will participate in two upcoming investor conferences. The H.C. Wainwright BioConnect Conference is scheduled for January 11-14, 2021, with a playback available at 6 a.m. EST on January 11. Additionally, the Oppenheimer Virtual Banking Meeting will occur during the same dates with one-on-one meetings only. BiomX focuses on developing natural and engineered phage therapies targeting bacteria affecting skin health and chronic diseases.

BiomX Inc. (NYSE American: PHGE), a clinical stage company developing natural and engineered phage therapies targeting specific pathogenic bacteria, today announced that Jonathan Solomon, Chief Executive Officer, will participate in the following upcoming investor conferences.

Event: H.C. Wainwright BioConnect Conference
Dates: January 11-14, 2021
Time: Playback available 6 a.m. EST January 11
Webcast link: BiomX - HCW BioConnect Conference Playback
The webcast will also be available in the Events section of the BiomX website at www.biomx.com.

Event: Oppenheimer Virtual Banking Meeting
Dates: January 11-14, 2021
1x1 meetings only

About BiomX

BiomX is a clinical-stage biotechnology company developing both natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of skin, as well as target bacteria in the treatment of chronic diseases, such as inflammatory bowel disease, primary sclerosing cholangitis, cystic fibrosis and colorectal cancer. BiomX discovers and validates proprietary bacterial targets and customizes phage compositions against these targets.

Additional information is available at www.biomx.com, the content of which does not form a part of this press release.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210104005096/en/

FAQ

What is BiomX's stock symbol?

BiomX's stock symbol is PHGE.

When will BiomX participate in the H.C. Wainwright BioConnect Conference?

BiomX will participate in the H.C. Wainwright BioConnect Conference from January 11-14, 2021.

How can I access the BiomX conference playback?

The playback for the BiomX conference will be available at 6 a.m. EST on January 11, 2021, through their website.

What type of therapies does BiomX develop?

BiomX develops natural and engineered phage therapies targeting specific pathogenic bacteria associated with skin health and chronic diseases.

What other event is BiomX participating in during January 2021?

BiomX is also participating in the Oppenheimer Virtual Banking Meeting from January 11-14, 2021, for one-on-one meetings.